Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 4
1968 5
1969 5
1970 2
1971 2
1972 4
1973 6
1974 7
1975 15
1976 11
1977 19
1978 18
1979 35
1980 37
1981 30
1982 48
1983 35
1984 38
1985 58
1986 66
1987 69
1988 77
1989 123
1990 148
1991 135
1992 156
1993 175
1994 192
1995 227
1996 264
1997 244
1998 261
1999 322
2000 364
2001 392
2002 388
2003 407
2004 393
2005 473
2006 408
2007 413
2008 427
2009 410
2010 414
2011 413
2012 388
2013 419
2014 414
2015 383
2016 389
2017 363
2018 321
2019 273
2020 304
2021 283
2022 261
2023 231
2024 65

Text availability

Article attribute

Article type

Publication date

Search Results

10,785 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial.
Ferrante KL, Wasenda EJ, Jung CE, Adams-Piper ER, Lukacz ES. Ferrante KL, et al. Female Pelvic Med Reconstr Surg. 2021 Feb 1;27(2):112-117. doi: 10.1097/SPV.0000000000000749. Female Pelvic Med Reconstr Surg. 2021. PMID: 31232721 Clinical Trial.
METHODS: This was an investigator-initiated, multicenter, single-blind, randomized, placebo-controlled trial of vaginal estrogen (delivered via ring or cream) compared with placebo. Postmenopausal women with documented rUTI were randomized to receive either vaginal estr
METHODS: This was an investigator-initiated, multicenter, single-blind, randomized, placebo-controlled trial of vaginal estrogen (del …
The effect of exogenous estrogen on depressive mood in women: A systematic review and meta-analysis of randomized controlled trials.
Zhang J, Yin J, Song X, Lai S, Zhong S, Jia Y. Zhang J, et al. J Psychiatr Res. 2023 Jun;162:21-29. doi: 10.1016/j.jpsychires.2023.04.002. Epub 2023 Apr 10. J Psychiatr Res. 2023. PMID: 37068417 Review.
The finding of meta-regressions that the effect of exogenous estrogen was associated with age in perimenopause and post-menopause rather than the dose or administration of exogenous estrogen, showed again that a stable level of estrogen is more beneficial tha …
The finding of meta-regressions that the effect of exogenous estrogen was associated with age in perimenopause and post-menopause rat …
Estrogen therapy and breast cancer in randomized clinical trials: a narrative review.
Pan K, Lavasani S, Aragaki AK, Chlebowski RT. Pan K, et al. Menopause. 2022 Sep 1;29(9):1086-1092. doi: 10.1097/GME.0000000000002021. Epub 2022 Aug 16. Menopause. 2022. PMID: 35969882 Review.
IMPORTANCE AND OBJECTIVE: In the Women's Health Initiative (WHI) randomized trial with 10,739 postmenopausal women with prior hysterectomy, conjugated equine estrogen (CEE) alone significantly reduced breast cancer incidence and breast cancer mortality. ...After full consi …
IMPORTANCE AND OBJECTIVE: In the Women's Health Initiative (WHI) randomized trial with 10,739 postmenopausal women with prior hysterectomy, …
Estrogen for schizophrenia.
Chua WL, de Izquierdo SA, Kulkarni J, Mortimer A. Chua WL, et al. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004719. doi: 10.1002/14651858.CD004719.pub2. Cochrane Database Syst Rev. 2005. PMID: 16235377 Review.
As these vulnerable periods to psychosis are associated with estrogen withdrawal, this hormone has been proposed as a treatment for schizophrenia. ...For negative symptoms, results favoured the estrogen and progesterone group (n=9, WMD PANSS negative subscale -9.0 C …
As these vulnerable periods to psychosis are associated with estrogen withdrawal, this hormone has been proposed as a treatment for s …
Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.
Whedon JM, KizhakkeVeettil A, Rugo NA, Kieffer KA. Whedon JM, et al. J Womens Health (Larchmt). 2017 Jan;26(1):18-28. doi: 10.1089/jwh.2015.5628. Epub 2016 Sep 7. J Womens Health (Larchmt). 2017. PMID: 27603786 Review.
Small trials examining the effects of bioidentical estrogens on depressive symptoms show conflicting results. We conducted a systematic review to assess the effectiveness and safety of bioidentical estrogens for treatment of depressive symptoms in peri- and postmeno …
Small trials examining the effects of bioidentical estrogens on depressive symptoms show conflicting results. We conducted a systemat …
Estrogen-based hormone therapy in women with primary ovarian insufficiency: a systematic review.
Burgos N, Cintron D, Latortue-Albino P, Serrano V, Rodriguez Gutierrez R, Faubion S, Spencer-Bonilla G, Erwin PJ, Murad MH. Burgos N, et al. Endocrine. 2017 Dec;58(3):413-425. doi: 10.1007/s12020-017-1435-x. Epub 2017 Oct 16. Endocrine. 2017. PMID: 29039146 Free PMC article. Review.
Randomized trials and observational cohort studies with an estrogen-based HT intervention in women with POI under the age of 40 were included. ...The most common HT formulations were transdermal estradiol and oral conjugated equine estrogen combined with medroxyprog …
Randomized trials and observational cohort studies with an estrogen-based HT intervention in women with POI under the age of 40 were …
Homocysteine, estrogen and cognitive decline.
Shah S, Bell RJ, Davis SR. Shah S, et al. Climacteric. 2006 Apr;9(2):77-87. doi: 10.1080/13697130600641282. Climacteric. 2006. PMID: 16698655 Review.
There are circumstantial data indicating a positive association between homocysteine and cognitive decline and that endogenous and exogenous estrogen may influence homocysteine levels. The aim of this review was to establish what is known of the relationships between cogni …
There are circumstantial data indicating a positive association between homocysteine and cognitive decline and that endogenous and exogenous …
Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse.
Rahn DD, Richter HE, Sung VW, Hynan LS, Pruszynski JE. Rahn DD, et al. Am J Obstet Gynecol. 2023 Sep;229(3):309.e1-309.e10. doi: 10.1016/j.ajog.2023.05.023. Epub 2023 May 25. Am J Obstet Gynecol. 2023. PMID: 37244454 Free PMC article. Clinical Trial.
Past evidence suggests that postmenopausal women with symptomatic prolapse gain benefit from the preoperative application of intravaginal estrogen, but it is unknown whether they would experience improvement in other pelvic floor symptoms when treated with intravaginal …
Past evidence suggests that postmenopausal women with symptomatic prolapse gain benefit from the preoperative application of intravaginal …
Efficacy of Low-Dose Estrogen-Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis.
Iwata M, Oikawa Y, Shimizu Y, Sakashita N, Shoji A, Igarashi A, Osuga Y. Iwata M, et al. Adv Ther. 2022 Nov;39(11):4892-4909. doi: 10.1007/s12325-022-02298-9. Epub 2022 Sep 1. Adv Ther. 2022. PMID: 36048405 Free PMC article. Review.
INTRODUCTION: Although several studies suggest beneficial effects of low-dose estrogen-progestins (LEPs) and progestins on dysmenorrhea in Japanese women, the difference in efficacy between drugs remains unknown. ...
INTRODUCTION: Although several studies suggest beneficial effects of low-dose estrogen-progestins (LEPs) and progestins on dysmenorrh …
Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies.
Stone JC, Clark J, Cuneo R, Russell AW, Doi SA. Stone JC, et al. Pituitary. 2014 Jun;17(3):284-95. doi: 10.1007/s11102-013-0504-2. Pituitary. 2014. PMID: 23925896 Review.
Estrogen and selective estrogen receptor modulator (SERM) treatments for acromegaly have received limited attention since the development of newer pharmacologic therapies. ...Therefore, the aim of this meta-analysis was to synthesise current evidence with a view to
Estrogen and selective estrogen receptor modulator (SERM) treatments for acromegaly have received limited attention since the
10,785 results
You have reached the last available page of results. Please see the User Guide for more information.